ESLICARBAZEPINE ACETATE | A211238 | DR REDDYS LABORATORIES LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
BIAL - PORTELA & CA S.A. et al v. Dr. Reddy's Laboratories, Ltd. et al 6 patentsANDA 211238Eslicarbazepine Acetate | D. Del. | 2018-03-02 | Terminated 2021-12-08 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$1.77
per ea
Lowest NADAC/Unit
$1.52
per ea
Brand NDCs
0
Generic NDCs
4
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 43598068430ESLICARBAZEPINE 200 MG TABLET | $1.77 | EA | Generic | — | 2026-10-21 |
| 43598068530ESLICARBAZEPINE 400 MG TABLET | $1.67 | EA | Generic | — | 2026-10-21 |
| 43598068660ESLICARBAZEPINE 600 MG TABLET | $1.62 | EA | Generic | — | 2026-10-21 |
| 43598068730ESLICARBAZEPINE 800 MG TABLET | $1.52 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.